脂代谢紊乱先于精神病发作
该研究对263例精神病临床高危(CHR)个体和51名健康对照进行血清脂质组学分析并随访至5年,发现基线脂质谱可区分CHR与对照,且以AUC 0.81(95%CI 0.69-0.93)的模型区分后续是否转化为精神病,转化者基线醚磷脂水平更低。
要点
- CHR个体基线三酰甘油(低酰基碳数与双键数)及总体脂质水平高于健康对照。
- 基线脂质谱模型区分CHR后是否转化为精神病,AUC为0.81(95%CI 0.69-0.93)。
- 后续转化为精神病者基线醚磷脂水平低于未转化者(p < .01)。
核心结论
- 脂质组学异常先于精神病发作出现,血液脂质组学指标可能有助于预测CHR个体中谁最可能发展为精神病。
研究设计与样本
- 对263例CHR个体和51名健康对照进行血清脂质组学分析,并临床随访至5年。
- 采用机器学习识别区分CHR与对照、以及区分不同临床结局CHR亚组的脂质谱。
主要发现
- 基线时CHR个体(不论结局)低酰基碳数和双键数的三酰甘油水平及总体脂质水平高于对照。
- 后续转化为精神病者(n = 50)与未转化者(n = 213)可基于基线脂质谱区分,模型AUC为0.81(95%CI 0.69-0.93)。
- 转化为精神病者基线醚磷脂水平低于未转化者(p < .01)。
关键数值与推荐
- 区分CHR后续是否转化为精神病的基线脂质谱模型AUC为0.81(95%CI 0.69-0.93)。
- 转化者与未转化者基线醚磷脂水平差异的P值小于.01。
临床怎么用
- 对CHR个体可考虑检测血清脂质组学,辅助评估未来精神病转化风险。
- 基线低醚磷脂水平或提示更高的精神病转化风险,需加强临床监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A key clinical challenge in the management of individuals at clinical high risk for psychosis (CHR) is that it is difficult to predict their future clinical outcomes. Here, we investigated if the levels of circulating molecular lipids are related to adverse clinical outcomes in this group. METHODS: Serum lipidomic analysis was performed in 263 CHR individuals and 51 healthy control subjects, who were then clinically monitored for up to 5 years. Machine learning was used to identify lipid profiles that discriminated between CHR and control subjects, and between subgroups of CHR subjects with distinct clinical outcomes. RESULTS: At baseline, compared with control subjects, CHR subjects (independent of outcome) had higher levels of triacylglycerols with a low acyl carbon number and a double bond count, as well as higher levels of lipids in general. CHR subjects who subsequently developed psychosis (n = 50) were distinguished from those that did not (n = 213) on the basis of lipid profile at baseline using a model with an area under the receiver operating curve of 0.81 (95% confidence interval = 0.69-0.93). CHR subjects who became psychotic had lower levels of ether phospholipids than CHR individuals who did not (p < .01). CONCLUSIONS: Collectively, these data suggest that lipidomic abnormalities predate the onset of psychosis and that blood lipidomic measures may be useful in predicting which CHR individuals are most likely to develop psychosis.
引用
- Dickens AM, Sen P, Kempton MJ, et al. Dysregulated Lipid Metabolism Precedes Onset of Psychosis. Biol Psychiatry. 2020. PMID: 32928501. doi:10.1016/j.biopsych.2020.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。